Document is current

Article History

Received: 4 December 2024

Accepted: 29 March 2025

First Online: 10 April 2025

Declarations

:

: Hitomi Sakai has received honoraria for lectures and medical writing support from Daiichi Sankyo, and speaker honorarium from Eli Lilly, Chugai Pharmaceutical Co., Ltd, and advisory role fee from Gilead Sciences. Naoki Hayashi has received grants from MSD, Chugai Pharmaceutical Co., Ltd. and Konica Minolta Japan. He has also received honoraria for lectures from Eli Lilly, Astrazeneca, Taiho, Eisai, Exact Science, Daiichi Sankyo, Novartis, Pfizer, and Chugai Pharmaceutical Co., Ltd. Yukinori Ozaki has received honoraria for lectures from Daiichi Sankyo, Pfizer, Kyowa Kirin, and Eli Lilly. Mayumi Iida is an employee of Eli Lilly Japan, and minor stockholders of Eli Lilly and Company. Tsutomu Kawaguchi is an employee of Eli Lilly Japan, and minor stockholders of Eli Lilly and Company. Masashi Wakabayashi has received honoraria for lectures from Nihon Medi-Physics Co., Ltd. Toshimi Takano has received honoraria for lectures from Chugai Pharmaceutical Co., Ltd., Daiichi Sankyo, and Eli Lilly.

: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Showa University Research Ethics Review Board (April 22, 2022/22-017-B).

: Owing to the retrospective nature of the study, we applied an opt-out method to obtain consent to participate in this study.